BLND Blend Labs, Inc. Insider Trading

Director Brian Niranjan Sheth bought 1,156,928 shares (1.16M) for $1,991,365.97 in 3 trades at BLND as stock trades -62.6% from 52-week high.

Director Brian Niranjan Sheth purchased 1,156,928 shares across 3 separate transactions on 2026-06-11, 2026-06-12, and 2026-06-15, bringing his holdings from 17,536,729 shares to 18,693,657 shares (+6.6% net increase). The blended purchase price of $1.72 comes as the stock trades at $1.68 current price, down -62.6% from its 52-week high of $4.49, positioning the buys near recent lows within the 52-week range of $1.18–$4.49. The company reported revenue of $30,843,000.00 (latest quarter) and net income of $-8,049,000.00, with annual revenue declining -23.7% year-over-year; the company was unprofitable over its most recent full fiscal year. Across his cross-ticker open-market history, Sheth's 20 prior buys show an average 90d return of -45.3% and a 90d win rate of 0.00%. His 5 prior trades at BLND are all recent buys (2026-06-03 through 2026-06-10) with no yet-measurable 30d or 90d outcomes.

Director Brian Sheth buys 1,118,935 shares ($1.9M) at BLND over 3 days; stock down 63.0% from 52-week high.

Brian Niranjan Sheth, a Director, executed 3 separate purchases totaling 1,118,935 shares for $1,882,390.91 between June 8–10, 2026, at prices ranging from $1.67 to $1.70 per share. His post-transaction holdings increased to 17,536,729 shares, a net addition of +6.8% versus pre-transaction holdings. The stock currently trades at $1.66, down 63.0% from its 52-week high of $4.49, while BLND's fundamentals show revenue of $30,843,000.00 in the latest quarter against net income of $-8,049,000.00, and full-year revenue declined -23.7% year-over-year. Notably, Sheth's 5 prior purchases at BLND (May 20–27, 2026) each posted positive 90-day returns ranging from +14.7% to +17.9%, indicating a strong pattern of well-timed entry points at this ticker, which provides context for assessing this larger accumulation near cyclical lows.

Director Sheth acquires 268,606 shares for $421,334.82 across 2 transactions; stock -63.9% from 52-week high amid -23.7% revenue decline

Brian Niranjan Sheth, as a director, executed 2 separate purchases totaling 268,606 shares for $421,334.82 at a blended average price of $1.57 on 2026-06-03 and 2026-06-05. This acquisition increased his holdings from 16,149,188 to 16,417,794 shares (+1.7%). The timing of this purchase follows a notable pattern: his 5 prior trades at BLND were each well-timed at the 90-day mark, with each posting gains between +14.7% and +17.9%. However, the current macro context is concerning—the company is unprofitable with an annual revenue decline of -23.7% and a stock price currently at -63.9% from its 52-week high of $4.49. An investor should note that this director's recent consistent pattern of well-timed accumulation at BLND contrasts sharply with deteriorating fundamentals (quarterly loss of $-8,049,000 on revenue of $30,843,000), creating a tension between the insider's accumulation signal and the company's financial trajectory that warrants close observation of near-term catalysts or operational developments.

Director Brian Niranjan Sheth bought 1,043,628 shares over 3 days (May 22-27) at $1.48 avg, raising stake to 16.15M shares amid unprofitable fundamentals

Brian Niranjan Sheth, a Director at Blend Labs, executed 3 separate purchases totaling 1,043,628 shares for $1,540,214.88 between May 22–27, 2026 at a blended average price of $1.48, increasing his holdings by 6.9% to 16,149,188 shares. This accumulation occurs while the company is unprofitable (net income of $-8,049,000 in the latest quarter), revenue has contracted 23.7% year-over-year, and the stock has fallen 65.3% from its 52-week high of $4.49. His prior 5 purchases at Blend over the preceding week (May 12–18) all demonstrated positive 90-day returns (ranging from +4.0% to +15.4%), establishing a pattern of consistent accumulation at depressed valuations. The current accumulation at $1.48, following this month-long buying pattern, represents sustained insider purchasing despite significant operational headwinds.

Director Brian Niranjan Sheth buys 777,178 shares at blended $1.49 (May 19–21), part of 5-trade sequence perfectly timed ahead of gains.

Brian Niranjan Sheth made 3 separate purchases totaling 777,178 shares for $1,158,139.78 on consecutive trading days (May 19–21, 2026), raising his holdings by 777,178 shares (+5.4% vs pre-transaction holdings). This transaction adds to a pattern of highly consistent buying at Blend Labs: his prior 5 trades at BLND (May 12–18) were all buys, and all 5 of those prior trades show positive 90-day returns ranging from +4.0% to +15.4%. The current market price of $1.52 is down 66.2% from the 52-week high of $4.49, placing these purchases in a materially depressed valuation window. The company's fundamentals show revenue of $30.8M in the latest quarter, negative net income of $-8.0M, annual revenue decline of -23.7%, and the company was unprofitable over its most recent full fiscal year, creating a high-risk environment. The consistency and timing of his recent BLND purchases, combined with the company's distressed financial position and steep drawdown from highs, make this accumulation noteworthy for investors monitoring insider behavior and capital allocation under stress.

Director Brian Niranjan Sheth bought 1,527,874 shares (1.53M) at blended $1.37 on BLND amid -23.7% YoY revenue decline and -$8.0M net loss

Brian Niranjan Sheth, a Director at Blend Labs, executed 3 separate purchases totaling 1,527,874 shares for $2,090,273.60 ($2.1M) between May 14–18, 2026, at prices ranging from $1.33 to $1.47, raising his holdings from 12,800,508 to 14,328,382 shares (+11.9%). The purchases come as the company reports a latest-quarter revenue of $30,843,000 with net income of -$8,049,000, alongside annual revenue decline of -23.7%, indicating material operational stress. The stock currently trades at $1.58, 64.8% below its 52-week high of $4.49, while Sheth's prior 5 buys at BLND all experienced negative 90-day returns (ranging from -44.2% to -47.1%), with a 0 of 5 win rate at the 90-day mark. This filing signals a Director continuing to accumulate during a period of operational headwinds and prior buy-timing disappointments at this same ticker.

Director Niranjan Sheth bought 1,951,635 shares (1.95M) for $2,789,589.98 across 3 days at BLND; stock down 67.5% from 52-week high.

Brian Niranjan Sheth, a Director at Blend Labs, made 3 separate purchases totaling 1,951,635 shares for $2,789,589.98 at a blended average price of $1.43 across May 11–13, 2026, expanding his holdings by 18.0% to 12,800,508 shares. The current price of $1.46 sits 67.5% below the 52-week high of $4.49, and the company faces structural headwinds: revenue declined 23.7% year-over-year to $30,843,000.00 in the latest quarter, with net income of negative $8,049,000.00, indicating the firm remains unprofitable on a full-year basis. Sheth's prior 5 purchases at this same ticker (November–December 2025) all had negative 90-day returns ranging from -44.2% to -47.1%, establishing a pattern in which none of his prior trades at BLND showed a positive 90-day outcome, providing historical context for how this latest accumulation sits within his track record at this specific company.

Director Brian Niranjan Sheth buys 1,309,823 shares of BLND for $4,068,721.26 across three days at $3.14, $3.09, $3.09

Director Brian Niranjan Sheth purchased 1,309,823 shares across three separate transactions from 2025-12-01 to 2025-12-03 at an average price of $3.11 per share, investing $4,068,721.26 in total. His post-transaction holdings increased from 9,539,050 shares to 10,848,873 shares, representing a net increase of 1,309,823 shares (+13.7% versus pre-transaction holdings). The concentrated purchase window and consistent pricing across the three days represents a substantial addition to his existing stake by a board-level insider.

Director Brian Niranjan Sheth purchases 69,934 shares across 2 transactions at BLND for $213,850.28

Brian Niranjan Sheth, a Director at Blend Labs, executed 2 separate purchases totaling 69,934 shares for $213,850.28, with trades occurring on 2025-11-24 and 2025-11-26 at blended average price of $3.06. His post-transaction holdings reached 9,539,050 shares, compared to pre-transaction holdings of 9,469,116 shares. The purchases represent incremental activity by a director-level insider, though without prior trading pattern context, the significance of this accumulation relative to his typical investment cadence cannot be determined.

Director Brian Niranjan Sheth buys 1,382,197 shares at Blend Labs (BLND) for $4,193,929.03 in 2 transactions

Director Brian Niranjan Sheth purchased 1,382,197 shares across two separate transactions on 2025-11-18 and 2025-11-19, totaling $4,193,929.03 at a blended average price of $3.03 per share. This purchase increased his holdings by 17.1% from 8,086,919 to 9,469,116 shares post-transaction, representing a substantial incremental investment by a board member. The dual-day execution and aggregate dollar commitment signal material director confidence in the company at current valuations, though the filing itself contains no disclosed rationale or scheduled transaction plans that would contextualize the timing or strategic intent.